Rejoice! Spring is officially here.
Hope you have a great end to the week, and for the fathers out there – enjoy Sunday!
TRADING HALTS
Somnomed (ASX:SOM) – Pending an announcement regarding a proposed capital raise.
Star Minerals (ASX:SMS) – Pending an announcement regarding a capital raise.
AMA Group (ASX:AMA) – Pending an announcement regarding a capital raise.
Okapi Resources (ASX:OKR) – Pending an announcement regarding a capital raise.
Emyria (ASX:EMD) – Pending an announcement regarding a capital raise.
Frontier Energy (ASX:FHE) – Pending an announcement regarding a plan of arrangement.
COMMODITY/FOREX/CRYPTO MARKET PRICES
Gold: US$1,968.7 (-0.03%)
Silver: US$23.25 (+0.01%)
Nickel (3mth): US$20,863/t (-1.04%)
Copper (3mth): US$8377.48/t (-0.03%)
Oil (WTI): US$81.26 (-0.68%)
Oil (Brent): US$84.63 (-0.71%)
Iron 62pc Fe: US$107.41/t (-0.91%)
AUD/USD: 0.65 (+0.7%)
Bitcoin: US$29,155.70 (-0.08%)
Across markets
Australian shares are poised to open lower to start the month of September. Shares were mostly lower after a late sell-off in New York with investors awaiting August’s jobs report, scheduled for release at 10.30pm AEST on Friday.
ASX futures were down 38 points or 0.5% to 7237 near 7am AEST.
- On Wall St: Dow -0.5% S&P -0.2% Nasdaq +0.1%
- In New York: BHP -0.5% Rio -0.4% Atlassian +0.9%
- Tesla +0.5% Apple +0.1% Amazon +2.2%
The local currency edged 0.1 per cent higher, keeping US65¢ within reach; the Bloomberg dollar spot index also advanced 0.3 per cent.
On bitstamp.net, bitcoin was 5 per cent lower to $US25,948 at 7.05am AEST.
The yield on the US 10-year note slipped 1 basis points to 4.11 per cent at 4.59pm in New York.
Source: AFR
For ASX small caps doing more than shipping lumps of iron ore and coal, China success has been elusive. This was highlighted by the recent board spat at infant formula Bubs Australia (ASX:BUB), the core issue being Bubs’ relationship with its Chinese distributor and related excess inventory problems.
Undeterred, low-key rival Nuchev (ASX:NUC) is planning a renewed push in China as it expands its Oli6 brand from goat’s milk to dairy formula.
As with Bubs, Nuchev had a China distributor that wasn’t working out and its own inventory hangover of $9.4 million of raw material.
Nuchev has now signed up with a new exclusive distributor, H&S, which has also taken a 19.9 per cent stake (with a performance-linked path to 34.9 per cent).
H&S has also committed to buying and distributing a minimum $20 million of Oli6 over the initial three years, which implies a decent leg up on the $2 million of sales Nuchev managed in the June quarter.
Nuchev chief Greg Kerr points to the ability of H&S to sell via retailers including 60 cross border e-tailers.
“When you do business in China you need a clear see-through in terms of inventory levels, otherwise you risk clogging up the market in an irresponsible way,” he says.
Currently, Nuchev derives an “underwhelming” 25 per cent of its sales from China, when the balance really should be 70 per cent China and 30 per cent Australia/New Zealand.
“In 12 to 18 months we see those numbers righting themselves,” he says.
In the medical device sector, Uscom (ASX:UCM) distinguishes itself from its peers by gleaning 70 per cent of its revenue from the Middle Kingdom.
But creating a beachhead there has taken more than a decade, with more than a dozen regulatory steps involved.
“The secret is process and patience and relationships,” says Uscom chief Rob Phillips. “You need to be prepared to take time with those relationships.”
Uscom’s flagship product – the Uscom1A cardiac blood flow monitor – had been approved by Chinese authorities, but the company has been hampered by new rules requiring its products to be made in China if they are to supply the local market.
Via a partnership with precision electronics manufacturer Foxconn, Uscom is girding for re-approval.
The ‘made in China’ rule has reduced Uscom’s China revenues by more than half, but the “impending resolution” of the issue heralds a return to growth.
The company also has Chinese marketing approval for blood pressure monitor BP+ and is confident of assent for Spirosonics, which measures pulmonary function.
Uscom has a $10 million market cap (supported by $2.2 million of cash) and Nuchev is worth around $15 million (with $7.5 million cash).
Company: Terra Uranium (ASX:T92)
Sector: Uranium
Deal Type: IPO
Raise Amount: $7.5M
Latest Entry Price: $0.20
Today’s Price Change: $0.14 Unchanged
Company: Patagonia Lithium (ASX:PL3)
Sector: Lithium
Deal Type: IPO
Raise Amount: $8.6M
Latest Entry Price: $0.20
Today’s Price Change: $0.15 +12.50%
Company: Gold Mountain Limited (ASX:GMN)
Sector: Lithium
Deal Type: Placement
Raise Amount: $2.25M
Latest Entry Price: $0.0075
Today’s Price Change: $0.0075 -11.76%
Company: Unith Ltd. (ASX:UNT)
Sector: AI/ChatGPT
Deal Type: Placement
Raise Amount: $4.5M
Latest Entry Price: $0.033 with a 1:1 UNTO
Today’s Price Change: $0.026 Unchanged
Company: Volt Resources Ltd. (ASX:VRC)
Sector: Battery Metals
Deal Type: Placement
Raise Amount: $5.75M
Latest Entry Price: $0.011
Today’s Price Change: $0.009 Unchanged
Company: Castle Minerals Ltd. (ASX:CDT)
Sector: Battery Metals/Base Metals
Deal Type: Placement
Raise Amount: $1.52M
Latest Entry Price: $0.02 with a 2:3 CDTOA
Today’s Price Change: $0.011 +4.76%
Company: Avenira Ltd. (ASX:AEV)
Sector: Phosphate
Deal Type: Placement
Raise Amount: $2.1M
Latest Entry Price: $0.01 with a 1:2 AEVO
Today’s Price Change: $0.0105 +5.00%
Company: Latrobe Magnesium Ltd. (ASX:LMG)
Sector: Magnesium
Deal Type: Placement
Raise Amount: $3M & $11.5M
Latest Entry Price: $0.10 with a 1:4 LMGO
Today’s Price Change: $0.049 -2.00%
Company: Askari Metals Ltd (ASX:AS2)
Sector: Mining
Deal Type: IPO
Raise Amount: $5.7M
Latest Entry Price: $0.35 with a 1:3 AS2O
Today’s Price Change: $0.26 +2.22%
Company: Tymlez Ltd (ASX:TYM)
Sector: Blockchain
Deal Type: IPO/On-market purchase
Raise Amount: $13.3M
Latest Entry Price: $0.004 with a 1:1 option
Today’s Price Change: $0.003 Unchanged
Company: iCandy (ASX:ICI)
Sector: Gaming & Digital Advertising
Deal Type: Placement
Raise Amount: $1.25M
Latest Entry Price: $0.02 with a 1:1 ICIOB
Today’s Price Change: $0.037 Unchanged
Company: Fatfish Group (ASX:FFG)
Sector: Fintech
Deal Type: Placement
Raise Amount: $1.5M
Latest Entry Price: $0.015 with a 1:2 FFGOA
Today’s Price Change: $0.012 -7.69%
Company: Paradigm Biopharma (ASX:PAR)
Sector: Biopharma
Deal Type: IPO Cornerstone
Raise Amount: $1M+
Latest Entry Price: $0.35
Today’s Price Change: $0.615 -8.21%
Company: ReNu Energy Limited (ASX:RNE)
Sector: Energy
Deal Type: Placement
Raise Amount: $1.46M
Latest Entry Price: $0.06 with a 1:1 RNEO
Today’s Price Change: $0.034 +9.68%
Company: Carly Holdings Ltd (ASX:CL8)
Sector: AI and Car subscription
Deal Type: Placement
Raise Amount: $1.25M
Latest Entry Price: $0.025 with a 1:2 CL8O
Today’s Price Change: $0.022 Unchanged
Company: Avecho Biotechnology (ASX:AVE)
Sector: CBD
Deal Type: Placement
Raise Amount: $5M
Latest Entry Price: $0.006 with a 3:2 AVEOA
Today’s Price Change: $0.006 -14.29%
Company: ECS Botanics Holdings Ltd (ASX:ECS)
Sector: Medicinal Cannabis
Deal Type: Placement
Raise Amount: $6.6M
Latest Entry Price: $0.033 with 1:2 ECSO
Today’s Price Change: $0.023 +4.55%
If you would like more information on future Peak deals, please don’t hesitate to get in touch.
Peak on 1300 304 460
No responses yet